I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| non-classical monocyte | 12 studies | 30% ± 19% | |
| classical monocyte | 12 studies | 28% ± 15% | |
| natural killer cell | 7 studies | 22% ± 8% | |
| ciliated cell | 7 studies | 24% ± 9% | |
| myeloid cell | 6 studies | 21% ± 5% | |
| macrophage | 6 studies | 28% ± 7% | |
| endothelial cell | 5 studies | 25% ± 5% | |
| microglial cell | 5 studies | 24% ± 8% | |
| B cell | 4 studies | 19% ± 2% | |
| CD8-positive, alpha-beta T cell | 4 studies | 26% ± 9% | |
| effector memory CD8-positive, alpha-beta T cell | 4 studies | 27% ± 11% | |
| epithelial cell | 4 studies | 31% ± 10% | |
| GABAergic neuron | 4 studies | 35% ± 16% | |
| glutamatergic neuron | 4 studies | 41% ± 20% | |
| monocyte | 4 studies | 30% ± 7% | |
| T cell | 3 studies | 19% ± 2% | |
| leukocyte | 3 studies | 19% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 24% ± 6% | |
| CD4-positive, alpha-beta T cell | 3 studies | 23% ± 6% | |
| hematopoietic precursor cell | 3 studies | 30% ± 7% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 20% ± 5% | |
| lymphocyte | 3 studies | 22% ± 3% | |
| gamma-delta T cell | 3 studies | 24% ± 4% | |
| astrocyte | 3 studies | 25% ± 1% | |
| basal cell | 3 studies | 28% ± 8% | |
| interneuron | 3 studies | 30% ± 18% | |
| neuron | 3 studies | 33% ± 2% |
